Niraparib

Common brands: Zejula, Vitamin D, Neurontin, Gralise, Gaba 300-Ezs

Top reporter: Glaxosmithkline Llc

Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Provitamin D2 Compound [EPC]Proton Pump Inhibitor [EPC]Osmotic Laxative [EPC]
21,927
Total Reports
12,696
Serious Reports
1,414
Death Reports
30
Reported Reactions
Death Report Ratio: High (6.45%)

Patient Demographics

Male
338
Female
13,708

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Niraparib.

# Reaction Reports % of Total
1 NAUSEA 5,771
9.6%
2 FATIGUE 5,226
8.7%
3 PLATELET COUNT DECREASED 4,112
6.8%
4 CONSTIPATION 4,103
6.8%
5 INSOMNIA 2,839
4.7%
6 BLOOD PRESSURE INCREASED 2,455
4.1%
7 HEADACHE 2,369
3.9%
8 OFF LABEL USE 2,241
3.7%
9 VOMITING 2,031
3.4%
10 DECREASED APPETITE 1,876
3.1%
11 ASTHENIA 1,855
3.1%
12 PRODUCT DOSE OMISSION ISSUE 1,855
3.1%
13 CARBOHYDRATE ANTIGEN 125 INCREASED 1,848
3.1%
14 HAEMOGLOBIN DECREASED 1,742
2.9%
15 DIZZINESS 1,599
2.7%
16 ANAEMIA 1,460
2.4%
17 DYSPNOEA 1,432
2.4%
18 WHITE BLOOD CELL COUNT DECREASED 1,403
2.3%
19 MALIGNANT NEOPLASM PROGRESSION 1,352
2.2%
20 RED BLOOD CELL COUNT DECREASED 1,346
2.2%
21 HYPERTENSION 1,310
2.2%
22 HEART RATE INCREASED 1,230
2.0%
23 ARTHRALGIA 1,221
2.0%
24 DIARRHOEA 1,142
1.9%
25 DRUG INEFFECTIVE 1,106
1.8%
26 NEUROPATHY PERIPHERAL 1,103
1.8%
27 MALAISE 1,075
1.8%
28 PAIN 1,060
1.8%
29 THROMBOCYTOPENIA 1,059
1.8%
30 DEATH 935
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.